Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

被引:124
|
作者
Qadri, Firdausi [1 ]
Wierzba, Thomas F. [3 ]
Ali, Mohammad [3 ,4 ]
Chowdhury, Fahima [1 ]
Khan, Ashraful I. [1 ]
Saha, Amit [1 ]
Khan, Iqbal A. [2 ]
Asaduzzaman, Muhammad [1 ]
Akter, Afroza [1 ]
Khan, Arifuzzaman [1 ]
Begum, Yasmin A. [1 ]
Bhuiyan, Taufiqur R. [1 ]
Khanam, Farhana [1 ]
Chowdhury, Mohiul I. [1 ]
Islam, Taufiqul [1 ]
Chowdhury, Atique I. [1 ]
Rahman, Anisur [1 ]
Siddique, Shah A. [1 ]
Chowdhury, Atique I. [1 ]
Rahman, Anisur [1 ]
Siddique, Shah A. [1 ]
You, Young A. [3 ]
Kim, Deok R. [3 ]
Siddik, Ashraf U. [1 ]
Saha, Nirod C. [1 ]
Kabir, Alamgir [1 ]
Cravioto, Alejandro [3 ]
Desai, Sachin N. [3 ]
Singh, Ajit P. [3 ]
Clemens, John D. [1 ,5 ]
机构
[1] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh
[2] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh
[3] Int Vaccine Inst, Seoul, South Korea
[4] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[5] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 18期
关键词
O1; DHAKA;
D O I
10.1056/NEJMoa1510330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. We conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic. METHODS Nonpregnant residents of Dhaka, Bangladesh, who were 1 year of age or older were randomly assigned to receive a single dose of oral cholera vaccine or oral placebo. The primary outcome was vaccine protective efficacy against culture-confirmed cholera occurring 7 to 180 days after dosing. Prespecified secondary outcomes included protective efficacy against severely dehydrating culture-confirmed cholera during the same interval, against cholera and severe cholera occurring 7 to 90 versus 91 to 180 days after dosing, and against cholera and severe cholera according to age at baseline. RESULTS A total of 101 episodes of cholera, 37 associated with severe dehydration, were detected among the 204,700 persons who received one dose of vaccine or placebo. The vaccine protective efficacy was 40% (95% confidence interval [CI], 11 to 60%; 0.37 cases per 1000 vaccine recipients vs. 0.62 cases per 1000 placebo recipients) against all cholera episodes, 63% (95% CI, 24 to 82%; 0.10 vs. 0.26 cases per 1000 recipients) against severely dehydrating cholera episodes, and 63% (95% CI, -39 to 90%), 56% (95% CI, 16 to 77%), and 16% (95% CI, -49% to 53%) against all cholera episodes among persons vaccinated at the age of 5 to 14 years, 15 or more years, and 1 to 4 years, respectively, although the differences according to age were not significant (P = 0.25). Adverse events occurred at similar frequencies in the two groups. CONCLUSIONS A single dose of the oral cholera vaccine was efficacious in older children (= 5 years of age) and in adults in a setting with a high level of cholera endemicity.
引用
收藏
页码:1723 / 1732
页数:10
相关论文
共 50 条
  • [1] Single-Dose Oral Cholera Vaccine in Bangladesh
    Azman, Andrew S.
    Luquero, Francisco J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07):
  • [2] Vaxchora: A Single-Dose Oral Cholera Vaccine
    Cabrera, Adriana
    Lepage, Jayne E.
    Sullivan, Karyn M.
    Seed, Sheila M.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (07) : 584 - 589
  • [3] Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial
    Qadri, Firdausi
    Ali, Mohammad
    Lynch, Julia
    Chowdhury, Fahima
    Khan, Ashraful Islam
    Wierzba, Thomas F.
    Excler, Jean-Louis
    Saha, Amit
    Islam, Md Taufiqul
    Begum, Yasmin A.
    Bhuiyan, Taufiqur R.
    Khanam, Farhana
    Chowdhury, Mohiul I.
    Khan, Iqbal Ansary
    Kabir, Alamgir
    Riaz, Baizid Khoorshid
    Akter, Afroza
    Khan, Arifuzzaman
    Asaduzzaman, Muhammad
    Kim, Deok Ryun
    Siddik, Ashraf U.
    Saha, Nirod C.
    Cravioto, Alejandro
    Singh, Ajit P.
    Clemens, John D.
    LANCET INFECTIOUS DISEASES, 2018, 18 (06): : 666 - 674
  • [4] Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia
    Ferreras, Eva
    Chizema-Kawesha, Elizabeth
    Blake, Alexandre
    Chewe, Orbrie
    Mwaba, John
    Zulu, Gideon
    Poncin, Marc
    Rakesh, Ankur
    Page, Anne-Laure
    Stoitsova, Savina
    Voute, Caroline
    Uzzeni, Florent
    Robert, Hugues
    Serafini, Micaela
    Matapo, Belem
    Eiros, Jose-Maria
    Quilici, Marie-Laure
    Pezzoli, Lorenzo
    Azman, Andrew S.
    Cohuet, Sandra
    Ciglenecki, Iza
    Malama, Kennedy
    Luquero, Francisco J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06): : 577 - 579
  • [5] Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia
    Poncin, Marc
    Zulu, Gideon
    Voute, Caroline
    Ferreras, Eva
    Muleya, Clara Mbwili
    Malama, Kennedy
    Pezzoli, Lorenzo
    Mufunda, Jacob
    Robert, Hugues
    Uzzeni, Florent
    Luquero, Francisco J.
    Chizema, Elizabeth
    Ciglenecki, Iza
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2018, 96 (02) : 86 - 93
  • [6] Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine
    Jackson, Sarah S.
    Chen, Wilbur H.
    FUTURE MICROBIOLOGY, 2015, 10 (08) : 1271 - 1281
  • [7] Update on CVD 103-HgR single-dose, live oral cholera vaccine
    McCarty, James
    Bedell, Lisa
    De Lame, Paul-Andre
    Cassie, David
    Lock, Michael
    Bennett, Sean
    Haney, Douglas
    EXPERT REVIEW OF VACCINES, 2022, 21 (01) : 9 - 23
  • [8] PaxVax CVD 103-HgR single-dose live oral cholera vaccine
    Levine, Myron M.
    Chen, Wilbur H.
    Kaper, James B.
    Lock, Michael
    Danzig, Lisa
    Gurwith, Marc
    EXPERT REVIEW OF VACCINES, 2017, 16 (03) : 197 - 213
  • [9] NEW INACTIVATED ORAL CHOLERA VACCINE
    OBERDOERSTER, F
    THILO, W
    ACTA MICROBIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1974, 21 (1-2): : 213 - 215
  • [10] Cholera vaccine inactivated oral.
    不详
    Drugs in R & D, 1999, 2 (3) : 193 - 194